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The potential impact of unpublished resultsDiscussions on publication bias have taught the clinical
community that selective (non)reporting of research results
will generally distort both the available evidence picture
and its clinical interpretation. Selective (non)reporting
may occur deliberately or non-deliberately. The first can,
for example, be the result of prejudiced decisions of
researchers or pharmaceutical companies to only publish
results that they consider favorable for their careers or
products. The latter can happen when authors or editors
think that only positive results are interesting for readers,
or when the research has been done in a (e.g., educational)
context or culture where publication of negative findings is
not current practice. Also, it is possible that investigators or
authorities, correctly or incorrectly, believe that full publi-
cation of results can be a threat to public safety [1]. All
these variants have the same implications, in the sense that
clinical decisions can be unfavorably affected, contributing
to suboptimal health care, or that opportunities for scientific
progress will be missed. Also, independent peer review and
the open scientific debate on such research are eliminated,
implying that the usual quality control by the scientific
community cannot take place. Moreover, when research
is not publicly reported, colleagues in the same field may
never know about it and they may needlessly repeat the
same experiments, while putting extra burdens on patients
and, in the biomedical domain, on laboratory animals.
Obviously, selective (non)publication is a major prob-
lem for systematic reviews that aim to present a comprehen-
sive and appropriate evidence picture. Although there have
been developed approaches to identify and deal with this
problem [2], selective publication may still go unnoticed.
The use of international trial registers has done much
good and may, when stringently applied, in the long run
minimize the problem for experimental research. However,
for non-experimental research, these registers do not (yet)
exist [3] and are not easy to implement with sufficient
coverage.
Of course, a key question is to what extent selective
(non)publication does occur and what its impact may be.
In this context, the article of McDonagh et al. provides
very important information. They examined the DERP
(Drug Effectiveness Review Project) systematic review0895-4356  2013 The Authors. Published by Elsevier Inc.
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Open access under CCreports published since 2003 for the use of FDA (US Food
and Drug Administration) preapproval and post marketing
documents to identify important unpublished evidence.
The authors found that a minority of FDA documents con-
tain unpublished evidence that can be highly useful in
resolving publication bias and selective outcome and anal-
ysis reporting, and conclude that FDA documents can
provide important unpublished evidence for systematic
reviews. Recommendations for further research and for im-
proving access to this important FDA information are pre-
sented. This important article should also stimulate active
investigations of similar sources of unpublished evidence
worldwide.
Additionally, Thaler and colleagues provide important
insights in the way unpublished information can play a role.
They systematically evaluated pooled-study publications
(PSPs) that present statistical analyses of multiple random-
ized controlled trials (RCTs) without a systematic literature
search or critical appraisal. These PSPs were excluded from
a systematic review of second-generation antidepressants
(SGAs). The authors report that PSPs of SGAs are almost
exclusively funded by the pharmaceutical industry and of-
ten include unpublished data on secondary outcomes and
subgroups that are not available in the primary publications.
They conclude that guidance for reviewers and a system to
assess susceptibility of PSPs to bias are required.
Guidance for reviewers is clearly a topic of more general
interest. Berkman and her team examined the interrater re-
liability of applying guidance for grading strength of evi-
dence in systematic reviews for the AHRQ (Agency for
Health Research and Quality) Evidence-based Practice
Center program. Based on data from two systematic re-
views, the investigators found that the interrater reliability
was highly variable for scoring strength of evidence do-
mains, and low for combining scores to reach overall
strength of evidence grades. Recommendations were made
to support reviewers and for future research focused on im-
proved methods in this field of evaluating complex bodies
of evidence. It is interesting to connect Berkman’s findings
to the recent paper by Mustafa et al. [4] from the GRADE
group, who found that trained individuals can reliably as-
sess the quality of evidence using the GRADE system.
Speaking about more adequate reporting of findings that
may be relevant to research and practice: case reports de-
serve more attention. According to Sun and co-workers,
case reports are widely used to generate hypotheses, to BY-NC-ND license.
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ical stories for educational purposes. However, there is
a need for more consistent quality in case reports. There-
fore, these authors propose publication standards for case
reports to improve manuscript quality and to enhance their
usefulness for education, research, and clinical purposes.
This paper precedes a broader initiative, entitled ‘‘Consen-
sus-Based Case Reporting (CARA) guidelines,’’ which will
be published by the Journal of Clinical Epidemiology,
along with other journals, later this year. We strongly en-
courage these groups to come together and agree on a single
checklist to avoid confusion. Such collaboration between
various initiatives on reporting standards has been highly
successful before: a similar collaboration is how CON-
SORT was born. Also, correctly using and harvesting the
wealth of information in routine administrative health care
databases has a huge potential of enriching the arena of
published data. Huber et al. provide an updated,
pharmacy-based chronic disease score (CDS), based on
a cohort study using medical claims data from insured per-
sons. The CDS showed reasonable predictive validity of fu-
ture health care utilization and medical expenditure. This
may support health care decision makers in planning care
delivery and allocating resources. Routine databases may
also be used as a reference for validating self-reported
health information. Parkinson’s team examined the level
of agreement between self-reported health and hospital ad-
ministration records of arthritis-related surgeries in older
women. Based on the good agreement between both sour-
ces, the authors support the use of self-reports surveys in
epidemiological studies of joint procedures when adequate
administrative data are not available or accessible. Also Teh
and her group studied the agreement between self-reported
health and medical records. They focused on octogenarians,
using medical records on specific cardiovascular diagnoses.
They concluded that the reliability of self-reported informa-
tion on specific cardiovascular conditions is modest in oc-
togenarians and is influenced by various factors,
especially the number of comorbities. When deciding
whether or not to use self-reporting of these conditions, par-
ticipants’ characteristics that may affect the level of agree-
ment should be considered.
Results to be achieved in real practice may not always
be well predicted by research based on randomized trials.
Among the reasons for this can be methodological chal-
lenges such as nonadherence and contamination. Using
model calculations, Brenner c.s. analyzed the potential
impact of these phenomena in RCTs evaluating endoscopic
screening for colorectal cancer. The authors conclude that,
in the era of widespread endoscopy use even outside
screening programs, RCTs may strongly underestimate
the effects of colorectal cancer screening and that addi-
tional analyses are crucial for disclosing the true screening
effects. Study participation was also evaluated in pediatric
clinical research. Based on a cross-sectional survey on all
clinical studies conducted in six pediatric clinicalinvestigation centers, Kaguelidou and co-workers evaluated
refusal rates. It was found that the refusal rate was low and
that it was influenced by characteristics of the studies and
the recruiting physicians. The authors make recommenda-
tions on how to further improve recruitment in pediatric
clinical research.
In a systematic review, which is an update of a similar
study in 2004 [5], Whiting et al summarize the current ev-
idence on the sources of bias and variation in studies of the
accuracy of diagnostic tests. Consistent evidence was found
for the effects of a number of sources of bias and variation,
having generally more impact on sensitivity than specific-
ity. Accordingly, decades after the appearance of early
work stressing the need for better diagnostic research
[6e8], there is still substantial room for improvement in
minimizing the potential for bias in primary diagnostic ac-
curacy studies.
Van Hoorde c.s. considered the well-known observation
that prediction models may perform poorly in other set-
tings. Using case studies on testicular and ovarian tumors,
they studied which model updating methods should be
applied for models of polytomous outcomes. Simple di-
chotomous methods behaved well when applied to polyto-
mous models. The results suggest that recalibration is
preferred, but when larger validation sets are available, re-
vision or even redevelopment can be a valid alternative.
A number of articles address the validity and perfor-
mance of instruments. Because there were limited data
on health-related quality of life (HRQL) in chronic ob-
structive pulmonary disease (COPD) patients with chronic
hypercapnic respiratory failure, Struik et al. assessed and
compared the performance of four instruments among pa-
tients with severe COPD. The Severe Respiratory Insuffi-
ciency (SRI) questionnaire performed slightly better than
the other three, the authors suggest the SRI to be the pre-
ferred HRQL instrument in patients with very severe
COPD. Nikolaus and co-authors developed an item pool
based on the patients’ perspective to construct a future
computerized adaptive test for fatigue in rheumatoid arthri-
tis. Using data from a large group of patients with rheuma-
toid arthritis, they provided an initially calibrated item
bank and showed which dimensions and items can be used
for the development of a multidimensional computerized
adaptive test for fatigue. Also starting from the patient’s
perceptions, Carlesso c.s. performed a cross-sectional sur-
vey of patients receiving manual physiotherapy, focusing
on the identification and occurrence of adverse responses
related to manual therapy and predictors of such responses.
Based on their findings, the authors conclude that for de-
veloping a comprehensive framework for defining adverse
responses in manual therapies, the patient perspective is in-
deed important.
While summary scores from methodological quality
scales (such as the PEDro scale) are often used, da Costa
et al. argued in an earlier paper that the use of such scores
should be discouraged and that the PEDro database be
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scale [9]. In a letter to the editors, Costa et al. comment on this
paper, and suggest further research on this topic.
We have received many positive responses to the series
by Cals and Kotz on effective writing and publishing scien-
tific papers. We therefore welcome the new one-pager in
this series, addressing ‘the discussion.’
J. Andre Knottnerus
Peter Tugwell
Editors
E-mail address: anneke.germeraad@maastricht
university.nl (J.A. Knottnerus)
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